| Gregory Jay, MD | |
|
593 Eddy St, Claverick 2, Providence, RI 02903-4923 | |
| (401) 854-2504 | |
| (401) 854-2519 |
| Full Name | Gregory Jay |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 593 Eddy St, Providence, Rhode Island |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225042419 | NPI | - | NPPES |
| 939025129 | Other | RI | RI MEDICARE GROUP NUMBER |
| 12/29/2008 | Other | MA | TUFTS HEALTH PLAN |
| 7003618 | Medicaid | RI | |
| 1225042419 | Other | RI | NPI |
| 01/11/2007 | Other | RI | NHPRI |
| 405506 | Other | RI | BCBSRI |
| 930035515 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD08395 (Rhode Island) | Primary |
| Entity Name | Brown Emergency Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962455022 PECOS PAC ID: 7214833169 Enrollment ID: O20040116000868 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.
The widely used cancer drug bevacizumab may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The results suggest that physicians should monitor patients' kidney health when prescribing this angiogenesis inhibitor.
Various human implantable medical devices have been developed in recent years, and they are being used in clinical filed. These devices include brain–machine interfaces, in which a chip is implanted into the brain to enable humans to move machines using only their thoughts, and deep brain stimulators for treating Parkinson's disease and other brain diseases.
This December marks the 40th anniversary of the Abramson Cancer Center of the University of Pennsylvania being designated a Comprehensive Cancer Center by the National Cancer Institute. To celebrate this momentous milestone, over 400 people gathered together early this month for an event recognizing the center's vast achievements in cancer research, patient care, and education during the last four decades.
Semtech Corporation, a leading supplier of analog and mixed-signal semiconductors, today announced it will contribute $25,000 to the UCLA Hospital System toward the development of a new treatment center at the Ronald Reagan UCLA Medical Center for teen and young adult cancer patients.
› Verified 2 days ago
| Entity Name | Affinity Physicians Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.
The widely used cancer drug bevacizumab may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The results suggest that physicians should monitor patients' kidney health when prescribing this angiogenesis inhibitor.
Various human implantable medical devices have been developed in recent years, and they are being used in clinical filed. These devices include brain–machine interfaces, in which a chip is implanted into the brain to enable humans to move machines using only their thoughts, and deep brain stimulators for treating Parkinson's disease and other brain diseases.
This December marks the 40th anniversary of the Abramson Cancer Center of the University of Pennsylvania being designated a Comprehensive Cancer Center by the National Cancer Institute. To celebrate this momentous milestone, over 400 people gathered together early this month for an event recognizing the center's vast achievements in cancer research, patient care, and education during the last four decades.
Semtech Corporation, a leading supplier of analog and mixed-signal semiconductors, today announced it will contribute $25,000 to the UCLA Hospital System toward the development of a new treatment center at the Ronald Reagan UCLA Medical Center for teen and young adult cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Jay, MD Po Box 9484, Providence, RI 02940-9484 Ph: (401) 854-2500 | Gregory Jay, MD 593 Eddy St, Claverick 2, Providence, RI 02903-4923 Ph: (401) 854-2504 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced European CE Mark approval of its new Epiducer™ lead delivery system for neurostimulation therapy. Unveiled at the Neurosurgery 2010 Congress in Lyon, France, the Epiducer lead delivery system is the first of its kind, allowing introduction of S-Series perc-paddle leads as well as multiple lead arrays through a single percutaneous entry point.
The widely used cancer drug bevacizumab may cause severe loss of protein from the kidney into the urine that can lead to significant kidney damage and can compromise the efficacy of cancer treatment, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The results suggest that physicians should monitor patients' kidney health when prescribing this angiogenesis inhibitor.
Various human implantable medical devices have been developed in recent years, and they are being used in clinical filed. These devices include brain–machine interfaces, in which a chip is implanted into the brain to enable humans to move machines using only their thoughts, and deep brain stimulators for treating Parkinson's disease and other brain diseases.
This December marks the 40th anniversary of the Abramson Cancer Center of the University of Pennsylvania being designated a Comprehensive Cancer Center by the National Cancer Institute. To celebrate this momentous milestone, over 400 people gathered together early this month for an event recognizing the center's vast achievements in cancer research, patient care, and education during the last four decades.
Semtech Corporation, a leading supplier of analog and mixed-signal semiconductors, today announced it will contribute $25,000 to the UCLA Hospital System toward the development of a new treatment center at the Ronald Reagan UCLA Medical Center for teen and young adult cancer patients.
› Verified 2 days ago
Dr. Robert A Partridge, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-519-1604 Fax: 401-272-0538 | |
Dr. Gregory R Lockhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-444-4000 Fax: 401-427-7795 | |
Ian M Jacobson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 330-493-4443 | |
Dr. Daniel Shanin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Carli Renske Reisdorf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6680 | |
Dr. Oriane Diana Longerstaey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 704-355-3181 | |
Rachel Smith Shain, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6489 Fax: 401-444-6662 |